Is End-Stage Renal Disease Tumor Suppressive? Dispelling the Myths.
Ontology highlight
ABSTRACT: The prevalence of end-stage renal disease is increasing worldwide. Malignancies accompanying end-stage renal disease are detected in approximately 120 individuals per 10,000 person-years. Most studies have suggested that end-stage renal disease causes carcinogenesis and promotes tumor development; however, this theory remains questionable. Contrary to the theory that end-stage renal disease is predominantly carcinogenic, recent findings have suggested that after controlling for biases and sampling errors, the overall cancer risk in patients with end-stage renal disease might be lower than that in the general population, except for renal and urothelial cancer risks. Additionally, mortality rates associated with most cancers are lower in patients with end-stage renal disease than in the gene
SUBMITTER: Migita T
PROVIDER: S-EPMC11430482 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA